News | January 15, 2014

ROI Awards Malolan Rajagopalan Grant to Develop Website, Mobile App to Track Radiotherapy Toxicity

January 15, 2014 — The Radiation Oncology Institute (ROI) has selected Malolan S. Rajagopalan, M.D., radiation oncology resident, University of Pittsburgh Cancer Institute, to receive a $20,000 grant for a project to compile best practices regarding the management of radiation therapy toxicity. Rajagopalan’s project proposal includes development of a website and mobile application that will give ROI the capability to continually update this material so that it will remain current. Combined, the website and mobile app will be comprehensive tools that will improve patient quality of life and treatment outcomes.
 
Rajagopalan and his team will develop the website and a mobile app, for Apple iOS phones and tablets, to allow physicians, nurses and physician assistants to quickly review and implement symptom management pathways and guidelines for patients and provide links to peer-reviewed literature and areas in need of further study. The site will provide comprehensive information, recommendations with evidence links and other published articles. The site will be structured to be a living document that selected experts will update. The mobile app will also include a drug prescription reference tailored for oncology, as well as a number of tools and references to guide clinicians on the go.
 
Rajagopalan’s team will form a multidisciplinary panel of radiation oncology specialists and various other fields such as palliative care and pulmonology to review all materials to ensure the quality and comprehensiveness of the information and resources provided. Each panel of approximately four to six members will include radiation oncologists from various institutions and, for diversity, at least one member who is not a radiation oncologist. The first two symptoms that will be addressed are the most prevalent side effects of radiation therapy: dermatitis and oral mucositis.
 
Together, the website and mobile app will compile and categorize both acute and late radiation symptom management strategies, and prioritize them by effectiveness and the levels of evidence that support them. Rajagopalan plans to unveil both for beta review and testing Sept. 14-17, 2014 at ASTRO’s 56th Annual Meeting in San Francisco.
 
“A multidisciplinary cancer treatment plan includes thorough consideration and accounting for the individual needs of each patient, particularly when treatment side effects significantly impact patient compliance and outcomes,” said ROI President Theodore Lawrence, M.D., Ph.D., FASTRO, and president, ROI. “We are excited that Rajagopalan’s project will provide us with the best approaches to mitigating adverse treatment effects and a platform that will permit us to continue to grow this valuable resource.”
 
For more information: www.roinstitute.org

Related Content

RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
Overlay Init